Geno J. Germano, Jr.

President & Chief Executive Officer at Elucida Oncology, Inc.

Geno J. Germano, Jr.

Geno J. Germano, Jr.

President & Chief Executive Officer at Elucida Oncology, Inc.

Overview
Career Highlights

Intrexon Corp.
Wyeth Corp.
Elucida Oncology, Inc.

RelSci Relationships

4006

Number of Boards

9

Birthday

1961

Age

58

Relationships
RelSci Relationships are individuals Geno J. Germano, Jr. likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Innovation Officer at The Medicines Co.

Relationship likelihood: Strong

Former Vice President & Controller at Wyeth Corp.

Relationship likelihood: Strong

Founder at Cerecor, Inc.

Relationship likelihood: Strong

Director at X-Vax Technology, Inc.

Relationship likelihood: Strong

Managing Director at G9 Capital Group LLC

Relationship likelihood: Strong

Director, President & Chief Executive Officer at SAGE Therapeutics, Inc.

Relationship likelihood: Strong

Founding Partner at Sarissa Capital Management LP

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Mersana Therapeutics, Inc.

Relationship likelihood: Strong

Former President, Europe Chapter at Healthcare Businesswomen’s Association

Relationship likelihood: Strong

Former General Manager at Biogen, Inc.

Relationship likelihood: Strong

Paths to Geno J. Germano, Jr.
Potential Connections via
Relationship Science
You
Geno J. Germano, Jr.
President & Chief Executive Officer at Elucida Oncology, Inc.
Education
Bachelor of Science in Pharmacy
Class of 1983

ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES IS DEDICATED TO EDUCATION, RESEARCH AND SERVICE IN THE HEALTH SCIENCES AND HEALTHCARE PROFESSIONS.

Memberships
Member
Current
Career History
President & Chief Executive Officer
Current

Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in New York, NY.

President
2016 - 2017

Intrexon Corp. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

President & General Manager, Specialty Care & Oncology
2009 - 2016

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Boards & Committees
Director
2012 - 2013

Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on more than 65 years of experience, we deliver quality medicines, vaccines and diagnostic products, complemented by genetic tests, biodevices and a range of services. We are working every day to better understand and address the real-world challenges faced by those who raise and care for animals in ways they find truly relevant.

Member, Advisory Board
Current

Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ.

Chairman of the Board
Prior

The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based biopharmaceutical companies, NPC focuses on research development, information dissemination, education and communication of the critical issues of evidence, innovation and the value of medicines for patients. The issues we select for examination and the researchers and academics we partner with position NPC as a uniquely credible and trusted voice in the biopharmaceutical research and health policy communities. Much of our research is published in peer-reviewed journals.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2009

To promote the preservation, protection and understanding of Lake George and its surrounding basin.

Political Donations
$5,000
2013
$5,000
2011
Transactions
Details Hidden

Elucida Oncology, Inc. raised money in a private placement transaction

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Geno J. Germano, Jr.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Geno J. Germano, Jr.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Geno J. Germano, Jr..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/geno-j-germano-jr-3688632
  • https://relationshipscience.com/person/geno-j-germano-jr-3688632